Bioada
Genomarker
An Interactive Data Management, Exploration, Enrichment and Prediction Platform — across genomics, transcriptomics, proteomics, and metabolomics.
The Platform
How Genomarker works: unified multi-omics data management, exploration, enrichment, and prediction — machine learning guided by biological knowledge.
Read more →Applications
Genomarker in practice: liquid biopsy, diagnostics pipelines, drug repurposing, therapeutic targets, and polygenic and clinical risk scores.
Read more →Results
Genomarker results: reproducible multi-omics biomarkers for breast, pancreatic, and Alzheimer's disease, plus the companion tools Xarang and HappyReader.
Read more →What is Genomarker?
Genomarker is An Interactive Data Management, Exploration, Enrichment and Prediction Platform developed by Bioada. It brings every major class of omics data — genomics, transcriptomics, proteomics, and metabolomics — into a single interactive environment, so the path from raw molecular data to a validated biomarker happens in one place.
Why it matters
Biomarker discovery has a reproducibility problem: candidate markers that look decisive in one dataset too often fail in the next. A large part of the problem is fragmentation — each omics layer is usually analyzed with its own toolchain, and the signals that only appear when the layers are combined are missed entirely.
Genomarker is the only platform that analyzes all omics types — genomics, transcriptomics, proteomics, and metabolomics — while directly addressing biomarker reproducibility. It combines machine learning with structured biological knowledge, so predictions are grounded in what is already known about genes, pathways, and disease rather than in correlation alone.
Explore the platform
- The platform — the four capabilities: data management, exploration, enrichment, and prediction.
- Applications — liquid biopsy, diagnostics pipelines, drug repurposing, therapeutic targets, and risk scores.
- Results — the evidence so far, and the companion tools Xarang and HappyReader.
Frequently asked questions
What is Genomarker?
Genomarker is An Interactive Data Management, Exploration, Enrichment and Prediction Platform developed by Bioada. It unifies genomics, transcriptomics, proteomics, and metabolomics data in a single environment for biomarker discovery.
What makes Genomarker different from other omics tools?
Genomarker is the only platform that analyzes all omics types — genomics, transcriptomics, proteomics, and metabolomics — while directly addressing the biomarker reproducibility problem.
What results has Genomarker produced?
Genomarker has produced liquid-biopsy biomarkers with above 95% sensitivity and specificity for breast cancer, pancreatic cancer, and Alzheimer's disease; pipeline biomarkers for Parkinson's disease and FSHD; and driver genes and therapeutic targets in glioblastoma, multiple sclerosis, and lung cancer.
Who is Genomarker for?
Genomarker is built for researchers, clinicians, and biopharma teams working with multi-omics data — from early biomarker discovery through diagnostics development, drug repurposing, and risk scoring.
How can I get access?
Genomarker access is currently provided on request. Email saed@midsi.academy to request access, or follow development on the Genomarker GitHub repository.
Request access to Genomarker
Genomarker access is currently provided on request. Tell us about your multi-omics study and we will follow up.